XML 31 R20.htm IDEA: XBRL DOCUMENT v3.5.0.2

Revenues (Tables)

9 Months Ended

Sep. 30, 2016

Segment Reporting [Abstract]

Summary of net revenue

The Company’s net revenues consisted of the following for the three and nine months ended September 30, 2016 and 2015:

	Three months ended September 30,								Nine months ended September 30,
	2016				2015				2016				2015
Products:
Acetadote	$	1,807,495			$	2,065,081			$	5,532,893			$	6,386,767
Omeclamox-Pak	752,808				691,120				2,154,596				2,393,495
Kristalose	3,671,397				3,939,294				10,915,276				12,160,037
Vaprisol	496,279				670,621				1,286,126				2,199,645
Caldolor	1,357,289				352,343				3,060,441				2,007,076
Ethyol	519,400				—				519,400				—
Other	187,085				166,589				475,388				334,543
Total net revenues	$	8,791,753			$	7,885,048			$	23,944,120			$	25,481,563

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration